BA.2 (a subvariant of omicron) was liable for 12.6 percent of COVID-19 infections in the United States in the week ending March 5. As such, the FDA has told doctors in 8 states to stop using COVID treatment.
Health care professionals in eight states have been advised to avoid using a COVID-19 medication as it may not be helpful against an Omicron coronavirus subvariant that is becoming more common.
Sotrovimab, a monoclonal antibody given to treat COVID-19, is no longer approved for us...